ProDentim vs BioGaia Prodentis: Which Oral Probiotic Is Better?

ProDentim — what we could verify

ProDentim is sold as a chewable soft tablet meant to be dissolved or chewed once a day, so the bacteria contact the teeth, gums, and saliva rather than passing straight to the gut. Its marketing lists three probiotic strains — Lactobacillus paracasei, Bifidobacterium lactis BL-04, and Lactobacillus reuteri — at an advertised 3.5 billion CFU, alongside supporting ingredients such as inulin, malic acid, tricalcium phosphate, and peppermint. You can see the full breakdown on our ProDentim ingredients page.

Those strains do appear in oral-microbiome research, so the formula is not implausible. But two limitations matter for a fair comparison. First, the label emphasizes a total CFU figure rather than a clearly disclosed strain identifier and dose for each organism, which makes it harder to line up against specific studies. Second — and more importantly — we could not locate published, independent clinical trials of the ProDentim finished product. That keeps ProDentim on the strain-level rung of the evidence ladder rather than the finished-product rung, a distinction we explain in do oral probiotics work? This is not a claim that ProDentim does nothing; it is a claim about what can and cannot be verified today.

BioGaia Prodentis — what we could verify

BioGaia Prodentis is a lozenge designed to dissolve slowly in the mouth, usually taken once a day after brushing. Its defining feature is a single, named blend the company calls L. reuteri Prodentis — a combination of two human-derived strains, Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289. According to BioGaia’s own product information, each lozenge contains a minimum of roughly 200 million live L. reuteri Prodentis, in a base of isomalt and xylitol with mint flavoring (specific variants add zinc or use different flavors and sweeteners). The manufacturer positions it as a daily aid for healthy gums and teeth and fresh breath, explicitly alongside — not instead of — regular brushing and flossing.

What distinguishes BioGaia on transparency is that it names the exact strain identifiers and points to the research behind that specific blend. That does not make the marketing claims automatically true: manufacturer statements about balancing the oral microbiome are still commercial claims, and a European regulatory panel has previously declined to authorize a general gum-health claim for an L. reuteri lozenge. But naming the strains at least lets an independent reader trace the evidence, which is exactly what the next section does.

ProDentim vs BioGaia Prodentis — strains and formulation

It is tempting to read this as “three strains versus two” and assume the bigger number wins. It does not work that way. Probiotic effects are strain-specific and dose-dependent: a benefit demonstrated for one named strain at a stated dose does not transfer to a different strain, a different dose, or even the same species with a different identifier. So the useful question is not how many strains a product contains, but which specific strains, at what dose, with what evidence.

On that measure the two products take different approaches. BioGaia bets on a narrow, precisely identified pair of L. reuteri strains that it has studied as a unit. ProDentim spreads across three strains and leads with a large combined CFU count, which looks impressive on a label but tells you little about any single strain’s contribution. A higher total CFU is not evidence of a stronger effect if the per-strain identity and dose are not specified. Format differs too: a lozenge and a chewable tablet both aim to keep bacteria in the mouth, and neither format is inherently superior — what matters is that the delivery suits the oral target and that live organisms survive to the point of use.

ProDentim vs BioGaia Prodentis — what does the research actually show?

This is the section that should drive any buying decision, so it is worth separating four very different kinds of evidence that marketing tends to blur together.

1. Oral probiotics in general. Systematic reviews find that certain oral probiotics can produce modest, mostly short-term effects — reducing decay-associated bacteria, and helping some gum measures when used alongside professional cleaning. The reviews consistently call for larger, longer, standardized trials. This is encouraging background for both products, but it pools many different bacteria together and proves nothing about either specific brand.
2. Specific strains. This is where probiotics are studied properly. L. reuteri in particular has the most gum-related research of the strains involved here, mostly as an adjunct to scaling and root planing, with benefits that are real but often short-lived and inconsistent across studies. We cover this in depth in our research explainer.
3. BioGaia Prodentis (the exact blend). The L. reuteri Prodentis combination (DSM 17938 + ATCC PTA 5289) has been tested in published human trials — including studies of oral-microbiota shifts and gingivitis in specific groups. The results are genuinely mixed: some trials report reductions in periodontal pathogens or improved clinical markers, while others found microbial changes without a matching clinical benefit. That is more finished-blend evidence than most consumer oral probiotics have, but it is not proof of a guaranteed result, and it does not establish that the product treats gum disease.
4. ProDentim (the finished product). We could not locate independent, published clinical trials of the ProDentim finished formula. Its strains have relevant research as individual organisms, but — as explained above — strain evidence is not product evidence. Importantly, BioGaia’s trial results cannot be transferred to ProDentim, and research on a single ProDentim strain cannot be transferred to the whole ProDentim formula.

The takeaway is not “BioGaia works and ProDentim doesn’t.” It is that the two sit at different points on the evidence ladder: BioGaia has published human data on its exact strain blend (with mixed findings), while ProDentim’s support is currently at the category and single-strain level rather than the finished-product level.

Which one is better for different goals?

Rather than an overall winner the evidence cannot support, it is more useful to match each product to a priority:

• If you want a specifically identified, well-documented strain blend: BioGaia Prodentis fits better, because it names its two L. reuteri strains and points to trials on that exact combination — even though those trials are mixed.
• If you prefer a chewable tablet and a multi-strain formula: ProDentim fits that preference, with three strains and added ingredients like inulin and peppermint — while keeping in mind the finished-product evidence gap.
• If published product-specific evidence is your priority: BioGaia has more human data on its actual blend; for ProDentim, the honest position is that finished-product trials are not available to verify.
• If you have a specific oral-health goal (for example active gum disease or persistent bad breath): neither product is a treatment. See a dentist for diagnosis, and treat any probiotic as a possible add-on to — never a replacement for — professional care.

Whichever direction you lean, verify the label yourself. You can check the ProDentim listing on Amazon or the BioGaia Prodentis listing on Amazon (both affiliate links), and confirm the format, strains, and live counts against each product’s current packaging. See our affiliate disclosure.

ProDentim vs BioGaia Prodentis — our verdict

There is no clinically proven, across-the-board winner here, and any page that declares one is overreaching. What we can say is more measured. If your priority is a transparently identified strain blend backed by published human research on that exact combination, BioGaia Prodentis is the better-documented choice — with the caveat that its trial results are mixed and it is not a treatment for gum disease. If you prefer a chewable, multi-strain format and are comfortable that the finished-product evidence is not established, ProDentim may suit your preference, provided you set realistic, short-term expectations.

For most readers the deciding factor is not the number of strains but how much verifiable evidence you require before spending money, and how you like to take a daily product. Keep up your brushing, flossing, and dental visits either way — that routine, not a probiotic, does the heavy lifting for oral health. If your shortlist also includes a mineral-based option, see our ProDentim vs DentiCore comparison.

Frequently asked questions

Sources & further reading

1. BioGaia. BioGaia Prodentis — product information and ingredients. biogaia.com
2. BioGaia Group. BioGaia Prodentis — strains and live count. biogaiagroup.com
3. Romani Vestman N, et al. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; a Randomized Control Trial. PLoS ONE. 2015. pmc.ncbi.nlm.nih.gov
4. Kõll-Klais P / Teughels W, et al. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis: a randomized clinical trial. 2012. pubmed.ncbi.nlm.nih.gov
5. Influence of the Probiotic L. reuteri on Periodontal Clinical Parameters after Nonsurgical Treatment: a systematic review. Microorganisms. 2023. mdpi.com
6. EFSA Panel on Nutrition. Scientific opinion on Lactobacillus reuteri lozenges and normal gum function. 2020. pubmed.ncbi.nlm.nih.gov
7. Probiotics for oral health: a critical evaluation of bacterial strains. Frontiers in Microbiology. 2024. frontiersin.org

Links point to peer-reviewed research and public health sources. Where a review reported mixed or non-significant results, we have described it that way rather than rounding it up. Content was summarized and paraphrased from the cited sources.